You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
通化金馬(000766.SZ):目前琥珀八氫氨吖啶片III期臨牀試驗揭盲後,已進入統計報吿、臨牀研究總結報吿及新藥註冊申請資料撰寫階段
格隆匯 12-05 16:16

格隆匯12月5日丨通化金馬(000766.SZ)公佈股票交易異常波動公吿,2023年9月21日,公司披露了《關於國家1.1類化學藥琥珀八氫氨吖啶片III期臨牀試驗揭盲結果的公吿》。目前琥珀八氫氨吖啶片III期臨牀試驗揭盲後,已進入統計報吿、臨牀研究總結報吿及新藥註冊申請資料撰寫階段。但新藥研發,尤其是國家1類新藥研發,受到技術、審批、政策等多方面因素的影響,相關研發進展及未來產品市場競爭形勢等均存在諸多不確定性風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account